Financhill
Back

Sangamo Therapeutics Stock Predictions

Sangamo Therapeutics Stock Forecast

  • Is Sangamo Therapeutics Stock Undervalued?
    The current Sangamo Therapeutics [SGMO] share price is $0.52. The Score for SGMO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SGMO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Sangamo Therapeutics Stock Go Up Next Year?

Data Unavailable

Sangamo Therapeutics Stock Rating

Data Unavailable

Sangamo Therapeutics Stock Price History

Is SGMO stock going to rise?

  • The current trend is relatively stagnant and SGMO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sangamo.com

52-Week Data

52-Week High:
1.67
52-Week Low:
0.29

Prediction Charts

Market Cap:
93.39M
Price in USD:
0.52
Volume:
746.61K
Beta:
2.23

Technical Analysis

SMA50:
0.73
SMA100:
0.64
SMA200:
0.69
52-Wk Change:
-61.9%

Stock Predictions

  • Is Sangamo Therapeutics stock public?
    Yes, Sangamo Therapeutics is a publicly traded company.
  • What is the Sangamo Therapeutics stock quote today?
    The Sangamo Therapeutics stock price is 0.52 USD today.
  • How to buy Sangamo Therapeutics stock online?
    You can buy Sangamo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-15 0.56 0.56 0.57 0.54
Apr-16 0.56 0.54 0.56 0.53
Apr-17 0.54 0.52 0.55 0.51
Apr-18 0.52 0.49 0.53 0.48
Apr-19 0.48 0.51 0.53 0.47
Apr-22 0.53 0.51 0.56 0.48
Apr-23 0.52 0.52 0.57 0.51
Apr-24 0.51 0.49 0.52 0.49
Apr-25 0.49 0.50 0.51 0.46
Apr-26 0.52 0.52 0.53 0.50
Apr-29 0.52 0.52 0.54 0.50
Apr-30 0.50 0.51 0.54 0.50
May-1 0.52 0.54 0.57 0.52
May-2 0.57 0.52 0.57 0.52

Sangamo Therapeutics Earnings

Data Unavailable

Sangamo Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $0.53 per share.

* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.